Anti-GM-CSF antibodies and uses thereof
US11926662B2 · kind B2 · utility
0Cited by
1References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 2, 2020 |
| Grant date | Mar 12, 2024 |
| Priority date | — |
| Expiry date | Oct 4, 2042 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/535
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided are anti-GM-CSF antibodies or fragments thereof including humanized antibodies and fragments. Also provided are uses of the antibodies and fragments for therapeutic, diagnostic and prognostic purposes. Therapeutic uses of the antibodies and fragments, for example include the treatment of inflammatory and autoimmune diseases and disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.